BeyondSpring(BYSI) - 2025 Q1 - Quarterly Results

EXHIBIT 99.1 BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update FLORHAM PARK, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a clinical‑stage global biopharmaceutical company focused on developing cancer therapeutics, today announced its unaudited financial results for the quarter ended March 31, 2025, and provided a corporate update. "Plinabulin has now been administered to more than 700 patients with a favorable safety profile. By promoting de ...